The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial

• Hauptverfasser: Mitrović Miloš (Verfasst von), Dobrosavljević Ana (Verfasst von), Odanović Olga (Verfasst von), Knežević-Ivanovski Tamara (Verfasst von), Kralj Đorđe (Verfasst von), Erceg Sanja (Verfasst von), Perućica Ana (Verfasst von), Svorcan Petar (Verfasst von), Stanković-Popović Verica (Verfasst von)
• Format: Buch
• Veröffentlicht: Sciendo, 2024-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Introduction: Metabolic Dysfunction-associated Liver Disease (MASLD) represents a spectrum of conditions from simple fat accumulation to non-alcoholic steatohepatitis. The possible role of the intestinal microbiome on MASLD development has been in focus. Our study aimed to examine the effects of syn...